Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “PRECISION BIOLOGICS, INC.”

27 pharma patents match "PRECISION BIOLOGICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 27
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 27 pharmaceutical patents matching "PRECISION BIOLOGICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

27 results for “PRECISION BIOLOGICS, INC.” · 30,257 patents in full index Clear search

  1. US 12344676

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted

  2. US 12037410

    Methods and compositions for targeting Treg cells

    PRECISION BIOLOGICS, INC. · Granted Jul 16, 2024 · Expires Jul 11, 2044

    granted

  3. US 11952429

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Apr 9, 2024 · Expires Apr 4, 2044

    granted

  4. US 11767367

    Monoclonal antibody neo-201 for the treatment of human carcinomas

    PRECISION BIOLOGICS, INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

    granted

  5. US 11572413

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043

    granted

  6. US 11505604

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted

  7. US 11401341

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted

  8. US 11345733

    Colon and pancreas cancer specific antigens and antibodies

    PRECISION BIOLOGICS, INC. · Granted May 31, 2022 · Expires May 26, 2042

    granted

  9. US 11279768

    Anti-cancer antibodies, combination therapies, and uses thereof

    PRECISION BIOLOGICS, INC. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

  10. US 11078245

    Colon and pancreas cancer peptidomimetics

    PRECISION BIOLOGICS, INC. · Granted Aug 3, 2021 · Expires Jul 29, 2041

    granted

  11. US 11001641

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted May 11, 2021 · Expires May 6, 2041

    granted

  12. US 10689443

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  13. US 10533040

    Colon and pancreas cancer peptidomimetics

    PRECISION BIOLOGICS, INC. · Granted Jan 14, 2020 · Expires Jan 9, 2040

    granted

  14. US 10364295

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 30, 2019 · Expires Jul 25, 2039

    granted

  15. US 10023650

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jul 17, 2018 · Expires Jul 12, 2038

    granted

  16. US 9938344

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Apr 10, 2018 · Expires Apr 5, 2038

    granted

  17. US 9718866

    Colon and pancreas cancer peptidomimetics

    PRECISION BIOLOGICS, INC. · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted

  18. US 9605077

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Mar 28, 2017 · Expires Mar 23, 2037

    granted

  19. US 9592290

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Mar 14, 2017 · Expires Mar 9, 2037

    granted

  20. US 9371375

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  21. US 9169326

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  22. US 9068014

    Colon and pancreas cancer peptidomimetics

    PRECISION BIOLOGICS, INC. · Granted Jun 30, 2015 · Expires Jun 25, 2035

    granted

  23. US 9034588

    Monoclonal antibody therapy for pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted May 19, 2015 · Expires May 14, 2035

    granted

  24. US 8802090

    Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

    PRECISION BIOLOGICS, INC. · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.